Previous studies have shown that the activation of NF‐κB and its signaling pathway in astrocytes and macrophages promote the progression of Alzheimer's disease (AD) and atherosclerosis (AS), making them potential targets for the treatment of AD and AS.30, 31. This evidence concerns the gene NFKB1 and Alzheimer disease.